Cargando…
Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery
Cancer remains a daunting and cureless disease, which is responsible for one-sixth of human deaths worldwide. These mortality rates have been expected to rise in the future due to the side effects of conventional treatments (chemotherapy, radiotherapy, and surgery), which can be addressed by applyin...
Autores principales: | Sun, Da, Chen, Jia, Wang, Yuan, Ji, Hao, Peng, Renyi, Jin, Libo, Wu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815958/ https://www.ncbi.nlm.nih.gov/pubmed/31660075 http://dx.doi.org/10.7150/thno.36510 |
Ejemplares similares
-
Advances in nanomedicine drug delivery applications for HIV therapy
por: Curley, Paul, et al.
Publicado: (2017) -
Targeted Delivery of Nanomedicines
por: Kumar Khanna, Vinod
Publicado: (2012) -
Recent Advances of Microfluidic Platforms for Controlled Drug Delivery in Nanomedicine
por: Ejeta, Fikadu
Publicado: (2021) -
Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
por: Kang, Xuejia, et al.
Publicado: (2023) -
Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery
por: Wang, Sheng, et al.
Publicado: (2020)